The DOI matches its Crossref record; 84 of the 85 references it cites were found in a registry or an index.
Asymmetrical Dimethylarginine: The Über Marker?
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Cardiovascular risk factors (e.g., hypercholesterolemia, diabetes mellitus) impair the synthesis and bioactivity of endothelium-derived NO (4, 5).”
From Dietary nitrate, nitric oxide, and restenosis (2011) · cites this paper as [4]
In the citing paper
“Their adverse effect on the NOS pathway is mediated by asymmetric dimethylarginine (ADMA; the endogenous antagonist of NO synthesis) and by the vascular generation of superoxide anion (O 2 -), which degrades NO to peroxynitrite anion (ONOO -) (4, 5).”
From Dietary nitrate, nitric oxide, and restenosis (2011) · cites this paper as [4]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Schächinger, V., Britten, M. B., & Zeiher, A. M. (2000) · Circulation · doi:10.1161/01.cir.101.16.1899 · Cited by 2,589
Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure
Leone, A., Moncada, S., Vallance, P., Calver, A., & Collier, J. (1992) · The Lancet · doi:10.1016/0140-6736(92)90865-z · Cited by 2,107
Long-Term Follow-Up of Patients With Mild Coronary Artery Disease and Endothelial Dysfunction
Suwaidi, J. M. S. A., Hamasaki, S., Higano, S. T., Nishimura, R. A., Holmes, D. R., & Lerman, A. (2000) · Circulation · doi:10.1161/01.cir.101.9.948 · Cited by 2,044
Superoxide generation by endothelial nitric oxide synthase: The influence of cofactors
Vásquez-Vivar, J., Kalyanaraman, B., Martásek, P., Hogg, N., Masters, B. S. S., Karoui, H., Tordo, P., & Pritchard, K. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9220 · Cited by 1,484
Böger, R. H., Bode-Böger, S. M., Szuba, A., Tsao, P. S., Chan, J. R., Tangphao, O., Blaschke, T. F., & Cooke, J. P. (1998) · Circulation · doi:10.1161/01.cir.98.18.1842 · Cited by 1,181
Self-citationZoccali, C., Bode-Böger, S. M., Mallamaci, F., Benedetto, F. A., Tripepi, G., Malatino, L. S., Cataliotti, A., Bellanuova, I., Fermo, I., Frölich, J. C., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(01)07217-8 · Cited by 1,087
Gokce, N., Keaney, J. F., Hunter, L. M., Watkins, M. T., Nedeljkovic, Z. S., Menzoı́an, J. O., & Vita, J. A. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00333-4 · Cited by 776
von der Leyen, H. E., Gibbons, G. H., Morishita, R., Lewis, N. P., Zhang, L., Nakajima, M., Kaneda, Y., Cooke, J. P., & Dzau, V. J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.4.1137 · Cited by 763
Self-citationEndogenous Nitric Oxide Synthase Inhibitor
Miyazaki, H., Matsuoka, H., Cooke, J. P., Usui, M., Ueda, S., Okuda, S., & Imaizumi, T. (1999) · Circulation · doi:10.1161/01.cir.99.9.1141 · Cited by 756
Self-citationNITRIC OXIDE SYNTHASE: Role in the Genesis of Vascular Disease
Cooke, J. P., & Dzau, V. J. (1997) · Annual Review of Medicine · doi:10.1146/annurev.med.48.1.489 · Cited by 706
Self-citation
Research works printed but not linked: 22
- 10.1161/atvb.16.1.44 · DOI
- 10.1161/circ.81.5.2139594 · DOI
- 10.1161/circ.104.4.448 · DOI
- 10.1161/circ.101.16.1899 · DOI
- 10.1161/circ.101.9.948 · DOI
- 10.1161/circ.99.9.1141 · DOI
- 10.1161/circ.101.8.856 · DOI
- 10.1161/circ.98.18.1842 · DOI
- 10.1161/atvb.20.9.2039 · DOI
- 2003, Circulation, 108, 1043
- 10.1161/atvb.20.4.1040 · DOI
- 10.1161/atv91.14.10.7918301 · DOI
- 10.1161/circ.89.5.8181143 · DOI
- 10.1161/circ.95.8.2068 · DOI
- 2003, Clin Nutr, 22, 23
- 10.1161/res.87.2.99 · DOI
- 10.1046/j.1523-1755.2001.07817.x · DOI
- 10.1161/circ.99.24.3092 · DOI
- 10.1161/circ.104.21.2569 · DOI
- 10.1161/circ.102.12.1414 · DOI
- 10.1161/circ.92.6.1539 · DOI
- 10.1001/jama.287.11.1420 · DOI
Cited by
Sorted by citations
Items 301–395 of 395
Vascular biomarkers in the metabolic syndrome
Thande, N. K., & Rosenson, R. S. (2009) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.09.2 · Cited by 4
Neopterin, homocysteine, and ADMA levels during and after urticaria attack
Tuncer, S. K., Kaldırım, Ü., Eyı, Y. E., Yıldırım, A. O., Ekinci, Ş., Kara, K., Eroğlu, M., Öztosun, M., Özyürek, S., Durusu, M., et al. (2015) · TURKISH JOURNAL OF MEDICAL SCIENCES · doi:10.3906/sag-1402-14 · Cited by 4
The Molecular Base of Exercise
Hambrecht, R. (2007) · Springer eBooks · doi:10.1007/978-1-84628-502-8_12 · Cited by 4
Aszimmetrikus dimetilarginin: a cardiovascularis betegségek prediktora?
Németh, B., Kustán, P., Németh, Á., Lenkey, Z., Cziráki, A., Kiss, I., Sulyok, E., & Ajtay, Z. (2016) · Orvosi Hetilap · doi:10.1556/650.2016.30396 · Cited by 4
Leopold, J. A. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-2930-6.00002-1 · Cited by 4
Miyazaki, K., Masaki, N., & Adachi, T. K. (2018) · Vascular Failure · doi:10.30548/vascfail.2.2_80 · Cited by 4
Pathomechanismen der Atherosklerose bei Diabetes mellitus
Mulac, K. (2005) · Journal für Kardiologie (Krause & Pachernegg GmbH) · Cited by 4
Amirkhizi, F., Taghizadeh, M., Hamedi-Shahraki, S., & Asghari, S. (2025) · Nutrition & Metabolism · doi:10.1186/s12986-025-00932-1 · Cited by 3
“Most cardiovascular risk factors have been suggested to negatively affect endothelial function through common pathogenic pathways that result in increased asymmetric dimethylarginine (ADMA) accumulation [11].”
Metabolomic Clusters and Their Association with Small Airway Disease in Asthma
Choi, J. Y., Kim, S. H., Pyung, Y. J., Yun, C., Rhee, C. K., Kim, D. K., & Lee, H. S. (2026) · Journal of Asthma and Allergy · doi:10.2147/jaa.s579350 · Cited by 3
Zhu, F., Zhou, C., Zheng, W., & Wang, D. W. (2019) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.1011 · Cited by 3
DDAH1 protein: biological functions, role in carcinogenesis processes
Prosekina, E. A., Shapkina, V. A., Karpov, A., Fedorutseva, E., & Artemyeva, A. S. (2025) · Russian Journal of Archive of Pathology · doi:10.17116/patol20258701160 · Cited by 3
Martins, J. D., Zachariah, J. P. V., Tierney, E. S. S., Truong, U. T., Morris, S. A., Kutty, S., de Ferranti, S. D., Rhodes, J., Antonio, M., Guarino, M. P., et al. (2018) · Annals of Pediatric Cardiology · doi:10.4103/apc.apc_64_18 · Cited by 3
Asymmetric dimethylarginine: Is it a risk facgtor in the repair of aortic coarctation?
Baş, T., Koç, M., Işık, O., Hançer, H., & Kutsal, A. (2021) · Journal of Cardiac Surgery · doi:10.1111/jocs.15601 · Cited by 3
Bilbao, A.-D. V., Goldschmied, J., Jang, A., Ehrmann, D. E., Kaplish, N., Pitt, B., Arnedt, J. T., Sen, S., Dalack, G. W., & Deldin, P. J. (2021) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2021.100814 · Cited by 3
Tveit, A., Arnesen, H., Smith, P., Bratseth, V., & Seljeflot, I. (2010) · Cardiology · doi:10.1159/000321402 · Cited by 3
Zapolski, T., Wysokiński, A. P., Książek, A., & Jaroszyński, A. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.06.111 · Cited by 3
Asymmetric Dimethylarginine Accelerates Cellular Senescence
Scalera, F., & Bode‐Böger, S. M. (2013) · Springer eBooks · doi:10.1007/978-94-007-7726-2_1 · Cited by 3
Asymmetric dimethylarginine (ADMA) and cardiovascular disease
Davids, M., & Teerlink, T. (2012) · Pure Amsterdam UMC · Cited by 3
Seljeflot, S. (2012) · Cardiology Research · doi:10.4021/cr175w · Cited by 3
Petrović, D., Jagić, N., Miloradović, V., & Stojimirovic, B. B. (2009) · Cited by 3
Raj, V. S., Charles, S., Ramasamy, M., Goenka, L., Kamatchi, M., George, M., Arockiaraj, J., Dhandapani, V. E., Angayarkanni, N., & Mala, K. (2019) · Process Biochemistry · doi:10.1016/j.procbio.2019.05.027 · Cited by 3
Maternal serum levels of asymmetric dimethylarginine in normal and preeclamptic pregnancies
Selanno, J. F., Riu, D. S., Tessy, T., Chalid, M. T., Pelupessy, N. U., & Hartono, E. (2020) · Gynecological Endocrinology · doi:10.1080/09513590.2019.1707793 · Cited by 3
Cardiac biomarkers and chronic renal diseases
Valocikova, I., Kristofová, B., & Valočík, G. (2008) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.1007/bf03657064 · Cited by 3
Michele, M. D., Risitano, A., Iacobucci, M., Amisano, P., Berto, I., Carnevale, R., Cammisotto, V., Pascariello, A., Beccia, M., Ciacciarelli, A., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-30283-z · Cited by 2
Asymmetric dimethylarginine as a marker of metabolic dysfunction and cardiovascular disease
Pai, J. K. (2008) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-008-0028-x · Cited by 2
L-Arginine and Its Methylated Derivatives in the Blood of Athletes
Gilinsky, M. A., Krivoshchekov, S. G., Latysheva, T. B., Naumenko, S. E., Гилинская, О. М., Айзман, Р. И., Golovin, M. S., Балиоз, Н. В., & Кармакулова, И. В. (2018) · Human Physiology · doi:10.1134/s0362119718060063 · Cited by 2
Translating Nitric Oxide Research to Therapeutics: A Critical Appraisal
Ray, A., Gulati, K., & Rehman, S. U. (2023) · Advances in biochemistry in health and disease · doi:10.1007/978-3-031-24778-1_1 · Cited by 2
Nitric Oxide Signalling in Vascular Control and Cardiovascular Risk
Schmidt, A. (2012) · InTech eBooks · doi:10.5772/34801 · Cited by 2
Mecanismos moleculares de la disfunción endotelial: de la síntesis a la acción del óxido nítrico
Guillermo, A. A., Añez, J., Andara, C., Bermúdez, V., & Arias, F. B. (2006) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 2
Inibidores da bomba de protões e o risco de eventos adversos graves – uma bomba cardiovascular?
Cunha, N., & Machado, A. P. (2018) · Revista Portuguesa de Cardiologia · doi:10.1016/j.repc.2017.10.012 · Cited by 2
Proton pump inhibitors and the risk of severe adverse events – A cardiovascular bombshell?
Cunha, N., & Machado, A. P. (2018) · Revista Portuguesa de Cardiologia (English Edition) · doi:10.1016/j.repce.2017.10.014 · Cited by 2
CVD in CKD: Focus on the Dyslipidemia Problem
Kassimatis, T. I., & Goldsmith, D. J. A. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0515-7_5 · Cited by 2
Endothelin 1, ADMA and SDMA in pregnancies with obstetric and thrombotic antiphospholipid syndrome
Mayer-Pickel, K. I., Kolovetsiou-Kreiner, V., Mörtl, M., Schlembach, D., Eberhard, K., Obermayer-Pietsch, B. M., Lang, U. E., & Cervar-Zivkovic, M. (2016) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2016.05.006 · Cited by 2
ADMA as a marker and mediator of endothelial dysfunction progression
Жлоба, А. А. (2007) · Arterial’naya Gipertenziya (Arterial Hypertension) · doi:10.18705/1607-419x-2007-13-2-119-127 · Cited by 2
DePace, N. L., & Colombo, J. (2019) · Springer eBooks · doi:10.1007/978-3-030-17016-5_4 · Cited by 2
Національний науковий центр «Інститут кардіології імені академіка М.Д. Стражеска» НАМН України, К., & В.О., Ш. (2021) · Український медичний часопис · doi:10.32471/umj.1680-3051.143.207515 · Cited by 2
Novel Markers for Adverse Events in Atrial Fibrillation
Cooke, J. P., & Sukhovershin, R. A. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.04.091 · Cited by 2
Self-citationAlmuqrin, A., Alrezaihi, A. F., Aljasser, A. A., Alqarni, I. R., Alshuweishi, Y., & Alfhili, M. A. (2025) · Healthcare · doi:10.3390/healthcare13233021 · Cited by 1
Qiu, Z., Xiong, F., Wang, Z., Zhao, Y., Gao, S., Zhang, X., Chen, Y., Liu, Z., Li, R., Cao, L., et al. (2026) · Science Translational Medicine · doi:10.1126/scitranslmed.aed4678 · Cited by 1
Cardiovascular morbidity and mortality risk factors in peritoneal dialysis patients
Jovanovic, D. B. (2008) · Srpski arhiv za celokupno lekarstvo · doi:10.2298/sarh0806313j · Cited by 1
Response to Cigarettes and ADMA: The Smoke Hasn’t Cleared Yet
Zhang, W., Venardos, K. M., Chin-Dusting, J. P. F., & Kaye, D. M. (2006) · Hypertension · doi:10.1161/01.hyp.0000239812.05676.1d · Cited by 1
Methylarginines in Mice with Experimental Atherosclerosis
Gilinsky, M. A., Sukhovershin, R. A., & Cherkanova, M. S. (2015) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-015-3086-3 · Cited by 1
Gudjoncik, A., Zeller, M., Lorin, J., Rigal, E., Cottin, Y., Vergely, C., & Rochette, L. (2016) · Clinical Trials and Regulatory Science in Cardiology · doi:10.1016/j.ctrsc.2016.01.005 · Cited by 1
The Levels of Asymmetric Dimethylarginine in Patients with Isolated Coronary Artery Ectasia
Erden, İ., Erden, E. Ç., Sözen, S. B., Kayapınar, O., Çağlar, S. O., & Başar, C. (2010) · Electronic Journal of General Medicine · doi:10.29333/ejgm/82893 · Cited by 1
Alfhili, M. A., Alsughayyir, J., Basudan, A., Alfaifi, M. A., Awan, Z. A., Algethami, M. R., & Al‐Sheikh, Y. A. (2023) · Journal of King Saud University - Science · doi:10.1016/j.jksus.2023.102699 · Cited by 1
Wilson, A., Harada, R. K., Nair, N., Balasubramanian, N., & Cooke, J. P. (2008) · Circulation · doi:10.1161/circulationaha.107.739052 · Cited by 1
Self-citationHerbal Viagra and nitric oxide: how hard is the evidence?
Cooke, J. P. (2010) · Cureus · doi:10.7759/cureus.13 · Cited by 1
Self-citationSerum Homocysteine and Intracranial Aneurysms
Tai, M. S., Toh, T. H., Hussain, H., & Ong, K. G. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.88570 · Cited by 1
Nutritional Impact on the Nitric Oxide Pathway
Wong, W. T., & Cooke, J. P. (2011) · Humana Press eBooks · doi:10.1007/978-1-60761-616-0_7 · Cited by 1
Self-citationCardiometabolic Antecedents of Preeclampsia
Jeyabalan, A., Hubel, C. A., & Davidge, S. T. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-818417-2.00017-8 · Cited by 1
Renal dysfunction and cardiovascular disease.
Soveri, I. (2006) · KTH Publication Database DiVA (KTH Royal Institute of Technology) · Cited by 1
Getting to the heart of the matter
Stuenkel, C. A. (2009) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e31818ffcf3 · Cited by 1
Translational research on exhaled volatile organic compounds from bedside to bench
Fijten, R. (2017) · doi:10.26481/dis.20171211rf · Cited by 1
Asymmetric Dimethylarginine in Pulmonary Arterial Hypertension
Thenappan, T. (2024) · JACC Heart Failure · doi:10.1016/j.jchf.2024.04.015 · Cited by 1
Transplant Arteriopathy: Role of Nitric Oxide Synthase
Nair, N., Valantine, H. A., & Cooke, J. P. (2006) · Springer eBooks · doi:10.1007/0-387-36279-3_20
Self-citationMetabolism of Methylarginines and Angiogenesis
Tsang, H., Iannone, L., & Wójciak‐Stothard, B. (2013) · Springer eBooks · doi:10.1007/978-3-7091-1428-5_11
Garcia, R. G., Silva, S., Ramírez, F., Silva, F., Pérez, M., & López-Jaramillo, P. A. (2005) · Redalyc (Universidad Autónoma del Estado de México)
Inflamación y riesgo cardiovascular en diálisis peritoneal
de Moraes, T. P., Ribeiro, S. C., & Pecoits‐Filho, R. (2009) · Elsevier eBooks · doi:10.1016/b978-84-8086-394-0.50020-4
The Endothelium, Cardiovascular Disease, and Therapy
Levine, T. B., & Levine, A. B. (2012) · Wiley eBooks · doi:10.1002/9781118480045.ch14
Endothelial Nitric Oxide Synthase, Nitric Oxide and Metabolic Disturbances in the Vascular System
Lutosawska, G. (2012) · InTech eBooks · doi:10.5772/36281
Hurr, C. (2013) · Texas ScholarWorks (Texas Digital Library)
Biliverdin reductase in cardiovascular inflammation
Sangha, J. (2011) · University of Birmingham Institutional Research Archive (University of Birmingham)
Purnomowati, A., Kariadi, S. H. K. S., Achmad, T. H., Mose, J. C., & Setianto, B. (2012) · Majalah kedokteran Bandung/Majalah Kedokteran Bandung · doi:10.15395/mkb.v44n1.72
Antoniades, C. A., Tousoulis, D., & Stefanadis, C. (2005) · Circulation · doi:10.1161/circulationaha.105.562058
Response to “Aerobic Exercise and Endothelial Function in Pre- and Post-Menopausal Women”
Tanahashi, K., Akazawa, N., & Maeda, S. (2014) · American Journal of Hypertension · doi:10.1093/ajh/hpu069
Study of the correlation between clinical efficiency of impaza and serum ADMA level
Zhavbert, E. S., Тарасов, С. А., Dugina, J. L., Sergeeva, S. A., Gamidov, S. I., Мазо, Е. Б., & Epstein, O. I. (2008) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-008-0093-7
Becker, R. C. (2005) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-005-1858-8
Meinitzer, A., & März, W. (2007) · Journal of Laboratory Medicine · doi:10.1515/jlm.2007.020
Purnomowati, A., Kariadi, S. H. K. S., Achmad, T. H., Mose, J. C., Setianto, B., Navarese, E. P., & Suryapranata, H. (2014)
Stuehlinger, M., Metzler, B., & Cooke, J. P. (2008) · Circulation · doi:10.1161/circulationaha.107.757062
Self-citationADMA: a mediator of endothelial dys- function and marker of vascular disease
Böger, R. H. (2004)
Pre-Diabetes, Cardiovascular Risk Factors, Arterial Stiffness—ADMA
Protopsaltis, I. D., Sarantos, K., & Papazafiropoulou, A. K. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-800093-9.00010-7
Can, F. (2012) · Istanbul Science University (Istanbul Bilim University)
Summo, C. (2013) · Elektronische Hochschulschriften der LMU München (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.15657
Originales, T., Garcia, R. G., Silva, S., Ramírez, F., Silva, F., & Pérez, M. (2005)
The vasoprotective properties of relaxin in the peripheral vasculature of males
Jelinic, M. (2016) · Minerva Access (University of Melbourne)
Nishida, H., Abe, H., Iida, Y., Toriyama, C., Yasumura, K., Yorifuji, H., Idemoto, A., Kato, T., Shinouchi, K., Mishima, T., et al. (2017) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.106.828
Teplan, V., & Ráček, J. (2012) · Wiley eBooks · doi:10.1002/9781118424032.ch10
Clinical Applications of Hydrophilic Interaction Liquid Chromatography
Wang, P. (2011) · Chromatographic science/Chromatographic science series · doi:10.1201/b10609-10
Bulut, F., TETİKER, A. T., Çelikkol, A., Şafak, A. S., Topçu, B., & Ballica, B. (2021) · Indian Journal of Otolaryngology and Head & Neck Surgery · doi:10.1007/s12070-021-02720-8
Correction of hypertensive retinal changes in rats with Semax
Lugovskoy, S. S., Chernyaeva, S. S., Пересыпкина, А. А., Победа, А. С., Solovev, N. V., Shchurovskaya, K. V., & Iezhitsa, I. N. (2021) · RESEARCH RESULTS IN BIOMEDICINE · doi:10.18413/2658-6533-2021-7-3-0-6
Nutritional Impact on the Nitric Oxide Pathway
Wong, W. T., & Cooke, J. P. (2017) · Springer eBooks · doi:10.1007/978-3-319-46189-2_9
Self-citationDodson, R. M., Kavalukas, S. L., & BARBUL, A. (2012) · Springer eBooks · doi:10.1007/978-3-642-00418-6_610
Fisiopatologia del sistema circolatorio
(2007) · Springer eBooks · doi:10.1007/978-88-470-0627-0_5
Rodrigues, F. S. M., Tallo, F. S., Caricati‐Neto, A., Finsterer, J., Scorza, C. A., & Scorza, F. A. (2025) · Clinics · doi:10.1016/j.clinsp.2025.100721
Uncu, G., Avcı, G. A., Eren, M., & Avcı, E. (2025) · Cureus · doi:10.7759/cureus.91814
Shambhavi, C., Yadav, S. K., Chauhan, P., & Gurjar, B. S. (2026) · doi:10.5005/jamu-11026-0018
Pizov, N. A., & Пизова, Н. В. (2026) · Russian neurological Journal · doi:10.30629/2658-7947-2026-31-2-51-59
Naser, I. A., AbuSaada, A. M. A., & Qedra, R. K. A. (2026) · BMC Cardiovascular Disorders · doi:10.1186/s12872-026-06178-w
Tsikas, D., Habler, K., & Ückert, P. S. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15145518
Fried, R. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-420046-3.00006-8
Metadata
- Authors
- Cooke, J. P.
- Affiliations
- Stanford Medicine (US)
- Corresponding author
- Cooke, John P.
- ORCID
- Cooke, John P.
- Venue
- Circulation
- Published
- 2004-04-20
- Volume
- 109
- Issue
- 15
- Pages
- 1813-1818
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2132464590
- Cited by
- 396
- References
- 85
- Citations by year
- 2026: 6 · 2025: 9 · 2024: 3 · 2023: 3 · 2022: 2 · 2021: 9 · 2020: 4 · 2019: 14 · 2018: 16 · 2017: 13 · 2016: 18 · 2015: 10 · 2014: 17 · 2013: 21 · 2012: 26
- FWCI
- 4.86
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Circulation (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Tobacco-Related Disease Research Program
- National Institute on Aging (P01 AG18784, P01AG018784)
- National Heart, Lung, and Blood Institute (R01 HL00204, R01 HL-HL63685, R01 HL, R01HL063685)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer-related gene regulation
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
- Keywords
- asymmetric dimethylarginine, nitric oxide bioavailability, endothelial dysfunction, oxidative stress, nitric oxide synthase
- MeSH terms
- Amidohydrolases, Arginine, Arteriosclerosis, Blood Vessels, Endothelium, Vascular, Humans, Risk Factors, Vascular Resistance, Biomarkers, Nitric Oxide Synthase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review